Skip to main content
Clinical Trials/IRCT20170308032957N2
IRCT20170308032957N2CompletedPhase 3

The effect of omega-3 on cancer related fatigue in cancer patients and its comparison with the control group

Isfahan University of Medical Sciences0 sites70 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Phase 3
Status
Completed
Enrollment
70

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
30 years to 60 years (—)
Sex
All

Inclusion Criteria

  • Age of 30 to 60 years for participants
  • Have definite diagnosis of cancer and indicate chemotherapy or undergo chemotherapy
  • Cancer related fatigue in patients with a score of 40 and above in the questionnaire
  • Ability to read and write by patients
  • Ability to eat an oral medication by patients
  • Lack of supplementation of omega-3 in the last 3 months
  • Insensitivity to fish
  • Lack of use of anticoagulants(except aspirin)
  • Insensitivity to soy
  • Lack of anemia
  • Satisfaction of patients to participate in the study

Exclusion Criteria

  • Patient's death during the study
  • Having a disease that is not able to participate in the study
  • more than 20% of the questionnaire has not been completed

Investigators

Similar Trials